Karman Holdings Inc. (NYSE:KRMN - Get Free Report)'s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $56.22, but opened at $52.48. Karman shares last traded at $50.94, with a volume of 289,328 shares traded.
Analysts Set New Price Targets
Several analysts have issued reports on the stock. Citigroup reaffirmed a "buy" rating and issued a $58.00 price target (up previously from $46.50) on shares of Karman in a report on Monday, June 9th. Robert W. Baird boosted their price objective on shares of Karman from $40.00 to $50.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 14th. Finally, Royal Bank Of Canada upped their target price on shares of Karman from $44.00 to $51.00 and gave the company an "outperform" rating in a research note on Thursday, July 3rd. Five investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $49.25.
Read Our Latest Report on KRMN
Karman Price Performance
The company has a quick ratio of 3.23, a current ratio of 3.34 and a debt-to-equity ratio of 1.15. The firm's 50 day moving average price is $46.15.
Karman (NYSE:KRMN - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.02 by $0.03. The company had revenue of $100.12 million during the quarter, compared to analyst estimates of $95.40 million. Karman's revenue was up 20.6% on a year-over-year basis.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of KRMN. Vanguard Group Inc. acquired a new position in shares of Karman during the first quarter worth approximately $61,024,000. Price T Rowe Associates Inc. MD bought a new position in Karman in the 1st quarter valued at $58,799,000. Invesco Ltd. bought a new position in Karman in the 1st quarter valued at $50,220,000. T. Rowe Price Investment Management Inc. purchased a new position in shares of Karman during the 1st quarter valued at $48,691,000. Finally, Alliancebernstein L.P. purchased a new position in shares of Karman during the 1st quarter valued at $37,182,000.
About Karman
(
Get Free Report)
We specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (“DoD”) and space sector initiatives.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Karman, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Karman wasn't on the list.
While Karman currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.